A‐Bin You

1.3k total citations
17 papers, 974 citations indexed

About

A‐Bin You is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, A‐Bin You has authored 17 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in A‐Bin You's work include Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (3 papers) and Cancer-related molecular mechanisms research (3 papers). A‐Bin You is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (3 papers) and Cancer-related molecular mechanisms research (3 papers). A‐Bin You collaborates with scholars based in China, Ethiopia and Romania. A‐Bin You's co-authors include Bingfeng Zuo, HaiFang Yin, Xianjun Gao, Zhen Lu, Quan Rao, Chenxuan Wu, Du Zhi, Ti Zhang, Dajun Deng and Wei Tian and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

A‐Bin You

17 papers receiving 967 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A‐Bin You China	14	780	444	217	136	97	17	974
Yusha Xiao China	14	489 0.6×	332 0.7×	89 0.4×	91 0.7×	180 1.9×	24	838
Wenli Diao China	16	345 0.4×	206 0.5×	209 1.0×	143 1.1×	35 0.4×	29	655
Kunitoshi Shigeyasu Japan	16	649 0.8×	308 0.7×	121 0.6×	202 1.5×	48 0.5×	67	951
Xuefeng He China	13	764 1.0×	546 1.2×	290 1.3×	218 1.6×	66 0.7×	33	1.1k
Qifeng He China	14	490 0.6×	302 0.7×	368 1.7×	328 2.4×	61 0.6×	23	942
Zhimeng Yao China	14	578 0.7×	303 0.7×	131 0.6×	132 1.0×	56 0.6×	26	741
Yamin Zhang China	13	344 0.4×	139 0.3×	98 0.5×	139 1.0×	79 0.8×	26	561
Yanzi Gu China	8	669 0.9×	486 1.1×	246 1.1×	180 1.3×	57 0.6×	13	876
Audrey Bouillez United States	14	640 0.8×	168 0.4×	262 1.2×	375 2.8×	44 0.5×	16	931
Leilei Liang China	20	832 1.1×	559 1.3×	191 0.9×	201 1.5×	39 0.4×	41	1.1k

Countries citing papers authored by A‐Bin You

Since Specialization

Citations

This map shows the geographic impact of A‐Bin You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A‐Bin You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A‐Bin You more than expected).

Fields of papers citing papers by A‐Bin You

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A‐Bin You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A‐Bin You. The network helps show where A‐Bin You may publish in the future.

Co-authorship network of co-authors of A‐Bin You

This figure shows the co-authorship network connecting the top 25 collaborators of A‐Bin You. A scholar is included among the top collaborators of A‐Bin You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A‐Bin You. A‐Bin You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

You, A‐Bin, et al.. (2023). CMTR1 promotes colorectal cancer cell growth and immune evasion by transcriptionally regulating STAT3. Cell Death and Disease. 14(4). 245–245. 13 indexed citations

You, A‐Bin, et al.. (2023). EZH2 inhibitor Tazemetostat synergizes with JQ-1 in esophageal cancer by inhibiting c-Myc signaling pathway. Medical Oncology. 40(10). 281–281. 6 indexed citations

You, A‐Bin, et al.. (2023). A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer. Clinical Cancer Research. 29(11). 2095–2109. 32 indexed citations

You, A‐Bin, et al.. (2022). TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern. Oncogene. 41(32). 3925–3938. 20 indexed citations

Chen, Ying, Zehua Li, Jing Ji, et al.. (2022). Single Cell RNA Sequencing Identifies a Unique Inflammatory Macrophage Subset as a Druggable Target for Alleviating Acute Kidney Injury. Advanced Science. 9(12). e2103675–e2103675. 115 indexed citations

Ding, Nan, A‐Bin You, Wei Tian, Liankun Gu, & Dajun Deng. (2020). Chidamide increases the sensitivity of Non-small Cell Lung Cancer to Crizotinib by decreasing c- MET mRNA methylation. International Journal of Biological Sciences. 16(14). 2595–2611. 44 indexed citations

Zuo, Bingfeng, Qi Han, Zhen Lu, et al.. (2020). Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice. Nature Communications. 11(1). 1790–1790. 137 indexed citations

Liu, Wensu, et al.. (2020). RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy. Epigenomics. 12(9). 801–809. 33 indexed citations

Cao, Manqing, A‐Bin You, Su Zhang, et al.. (2020). Cross talk between oxidative stress and hypoxia via thioredoxin and HIF‐2α drives metastasis of hepatocellular carcinoma. The FASEB Journal. 34(4). 5892–5905. 22 indexed citations

10.

Cao, Manqing, A‐Bin You, Xiao‐Dong Zhu, et al.. (2018). miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. Journal of Hematology & Oncology. 11(1). 12–12. 177 indexed citations

11.

Jing, Renwei, Xiaoli Zhou, Yushuang Wei, et al.. (2018). Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and humans in vitro. Hepatology. 68(4). 1391–1411. 16 indexed citations

12.

Cao, Manqing, A‐Bin You, Hongyuan Zhou, et al.. (2017). [Effect of HIF-2α on regulating CDCP1 to promote hepatocellular carcinoma metastasis].. PubMed. 39(1). 18–23. 1 indexed citations

13.

You, A‐Bin, Manqing Cao, Bingfeng Zuo, et al.. (2016). Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models. Journal of Hematology & Oncology. 9(1). 20–20. 57 indexed citations

14.

Rao, Quan, A‐Bin You, Bingfeng Zuo, et al.. (2016). Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models. PLoS ONE. 11(1). e0148263–e0148263. 10 indexed citations

15.

Rao, Quan, Bingfeng Zuo, Zhen Lu, et al.. (2016). Tumor‐derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro. Hepatology. 64(2). 456–472. 235 indexed citations

16.

Cao, Manqing, A‐Bin You, Hongyuan Zhou, et al.. (2016). Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30. Cancer Science. 107(4). 507–513. 31 indexed citations

17.

Cao, Manqing, Hongyuan Zhou, A‐Bin You, et al.. (2015). HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma. Tumor Biology. 37(2). 1651–1662. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact